De Ceunynck Radiotherapy
0680.604.062 · rovalta.com · 25/09/2026
ACTIVE
De Ceunynck Radiotherapy
Financial year 2024 · Closed on 31/12/2024
Net result-400,5 k €+72,1 %over 1 year
Gross margin82,8 k €+153,2 %over 1 year
Equity-1,6 M €-33,4 %over 1 year
Workforce2,5 ETP-28,6 %over 1 year
Overview
Identity
Source · BCE/KBODe Ceunynck Radiotherapy is a Public limited company incorporated in 2017. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Aartselaar. It employs on average 2,5 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0680.604.062
- Incorporation
- 28/08/2017
- Legal form
- Public limited company
- Registered office
- Kontichsesteenweg 36
2630 Aartselaar · FlandreSee on map - Contributed capital
- 62 000,00 €
- Latest accounts
- 31/12/2024
- Average workforce
- 2,5 ETP
Activities (NACE)
21209Manufacture of pharmaceutical preparations· main21209Manufacture of pharmaceutical preparations46460Wholesale of pharmaceutical goods46460Wholesale of pharmaceutical goods26600Manufacture of irradiation, electromedical and electrotherapeutic equipment26600Manufacture of irradiation, electromedical and electrotherapeutic equipment+4
Signals
Healthy social debts
Financials
Source · NBB, 7 filingsTrend over 7 financial years
| 2024 | 2023 | 2022 | 2021 | 2020 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 82,8 k € | +153% | -155,5 k € | -120% | 766,5 k € | -20.8% | 967,9 k € | +681% | -166,6 k € |
| EBITDA | -293,4 k € | +78.3% | -1,4 M € | -408% | 439,4 k € | -34.2% | 668 k € | +358% | -259,2 k € |
| Operating result | -336,1 k € | +75.7% | -1,4 M € | -427% | 422,4 k € | -36.2% | 662,1 k € | +340% | -275,9 k € |
| Net result | -400,5 k € | +72.1% | -1,4 M € | -589% | 292,9 k € | -52.5% | 616,6 k € | +299% | -309,8 k € |
| Balance sheet | |||||||||
| Equity | -1,6 M € | -33.4% | -1,2 M € | -614% | 233,5 k € | +493% | -59,4 k € | +91.2% | -676 k € |
| Total assets | 635 k € | -18.6% | 780 k € | -65.2% | 2,2 M € | -66.4% | 6,7 M € | +17.8% | 5,7 M € |
| Cash | 92 k € | +21.6% | 75,6 k € | -89.7% | 736,7 k € | +243% | 214,5 k € | -28.0% | 298 k € |
| Debts | 2,2 M € | +19.3% | 1,9 M € | -1.4% | 1,9 M € | -71.8% | 6,7 M € | +6.2% | 6,3 M € |
| Other | |||||||||
| Workforce | 2,5 ETP | -28.6% | 3,5 ETP | -12.5% | 4,0 ETP | +186% | 1,4 ETP | +40.0% | 1,0 ETP |
Board of directors
Source · NBB, accounts to 31/12/20243 active · 5 ended
Active mandates
Erik De Ceunynck
ActiveJozef Van Dam
ActivePeter Dejonge
ActiveEnded mandates
Erik De Ceunyck
EndedErik De Ceunynck
EndedJozef Van Dam
EndedEric De Ceunynck
EndedOther companies at this address
Kontichsesteenweg 36 2630 Aartselaar| Company | CBE no. |
|---|---|
DE CEUNYNCK MEDICAL● Active | 0456.155.465 |
De Ceunynck Services● Active | 0435.668.273 |
E & J● Active | 0679.666.528 |
VISION PARTNERS● Active | 0447.962.925 |
Financials
Full financial information
Source · NBB| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 |
| Closing of the financial year | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 29/08/2025 | 03/07/2025 | 03/04/2024 | 28/10/2022 | 30/09/2021 | 30/10/2020 |
| General meeting | 19/06/2025 | 28/10/2024 | 02/06/2023 | 03/06/2022 | 04/06/2021 | 30/06/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 7 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2024 | 19/06/2025 | 29/08/2025 | Dutch | |
| Abridged model | 31/12/2023 | 28/10/2024 | 03/07/2025 | Dutch | |
| Abridged model | 31/12/2022 | 02/06/2023 | 03/04/2024 | Dutch | |
| Abridged model | 31/12/2021 | 03/06/2022 | 28/10/2022 | Dutch | |
| Abridged model | 31/12/2020 | 04/06/2021 | 30/09/2021 | Dutch | |
| Abridged model | 31/12/2019 | 30/06/2020 | 30/10/2020 | Dutch | |
| Abridged model | 31/12/2018 | 07/06/2019 | 25/06/2019 | Dutch |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20243 active · 5 ended
Active mandates
Erik De Ceunynck
ActiveJozef Van Dam
ActivePeter Dejonge
ActiveEnded mandates
Erik De Ceunyck
EndedErik De Ceunynck
EndedJozef Van Dam
EndedEric De Ceunynck
EndedOwnership and network
Looking for more information about this company?
Try for 7 daysPublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2024Annual accounts 2024-400,5 k €↑
- 2023Annual accounts 2023-1,4 M €↓
- 2022Annual accounts 2022292,9 k €↓
- 2021Annual accounts 2021616,6 k €↑
- 2020Annual accounts 2020-309,8 k €↓
- 2019Annual accounts 2019-199,4 k €↑
- 2018Annual accounts 2018-228,7 k €
- 28/08/2017IncorporationPublic limited company